Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions

Antonio Russo, Lorena Incorvaia, Viviana Bazan, Daniele Fanale, Giuseppe Badalamenti, Chiara Brando, Carlo Messina, Camillo Porta, Mimma Rizzo, Mattia Rediti, Juan Lucio Iovanna, Daniel Olive

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions'. Together they form a unique fingerprint.

Medicine & Life Sciences